National Bank of Canada’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.3M Buy
260,929
+128,294
+97% +$9M 0.02% 480
2025
Q1
$9.74M Sell
132,635
-45,178
-25% -$3.32M 0.01% 605
2024
Q4
$11.7M Buy
177,813
+19,484
+12% +$1.28M 0.01% 554
2024
Q3
$12.3M Buy
158,329
+55,473
+54% +$4.32M 0.01% 528
2024
Q2
$8.01M Sell
102,856
-107,511
-51% -$8.38M 0.01% 547
2024
Q1
$16.2M Sell
210,367
-301,829
-59% -$23.3M 0.02% 391
2023
Q4
$35M Sell
512,196
-290,414
-36% -$19.9M 0.06% 247
2023
Q3
$53.4M Sell
802,610
-10,356
-1% -$689K 0.08% 168
2023
Q2
$53.4M Buy
812,966
+77,664
+11% +$5.1M 0.1% 151
2023
Q1
$51.2M Buy
735,302
+516,453
+236% +$35.9M 0.13% 123
2022
Q4
$14.8M Buy
218,849
+1,987
+0.9% +$135K 0.04% 302
2022
Q3
$11.8M Sell
216,862
-5,906
-3% -$321K 0.06% 297
2022
Q2
$14.7M Sell
222,768
-319
-0.1% -$21.1K 0.07% 249
2022
Q1
$15.2M Sell
223,087
-109,820
-33% -$7.48M 0.04% 271
2021
Q4
$19.4M Buy
+332,907
New +$19.4M 0.07% 203